News
Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...
GLP-1 medications are delivering a $6.5 billion blow to U.S. grocery spending, with weight-loss drugs altering consumer purchasing patterns.
Many US employers plan to pare health benefits as weight-loss spending soars - Nation and World News | Hawaii Tribune-Herald ...
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
Could weight loss drugs like Ozempic help combat addiction? STAT explores the question in our weekly video series.
Actress and comedian Kym Whitley, known for her role in Happy Gilmore 2, has partnered with Zepbound to aid in her weight loss journey over the past year.
Explore more
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...
The actress and comedian talks about her experience with Zepbound, and how it's contributed to her bigger health goals ...
15h
OK Magazine on MSNKym Whitely Says 'Young & Hungry' Cast Would Love to 'Come Back' Together: 'We're Lifelong Friends'Kym Whitely is not opposed to bringing her Young & Hungry cast together again. Though the show, which ran from 2014 to 2018, ...
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.
Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results